IT:NYSEGartner, Inc. Analysis
Data as of 2026-06-13 - not real-time
$148.17
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Gartner's stock trades at $148.17, well below its DCF‑derived fair value of $185.1, indicating a discount of roughly 12.7%. The price‑to‑earnings multiple of 14.6 is far beneath the industry average of 36.8, further underscoring undervaluation. However, the 30‑day volatility of over 52% and a decreasing volume trend point to heightened short‑term price swings. Technical indicators are mixed: the 20‑day SMA ($159.3) sits above the current price, while the MACD histogram is negative and the signal line is bearish, suggesting downward momentum. The RSI at 40 signals that the stock is not yet oversold, leaving room for buyers. The company posted a Q1 2026 earnings beat on Insights revenue, adjusted EBITDA and free cash flow, providing a positive earnings momentum.
Management highlighted strong new business with enterprise leaders despite a slowdown in March due to geopolitical factors. A class‑action securities‑fraud lawsuit filed in May adds a material legal headwind that could affect investor sentiment. Gartner’s operating margin of 20.5% and free cash flow generation of $1.06 bn demonstrate robust profitability and cash generation. The balance sheet shows a high debt‑to‑equity ratio driven by substantial cash holdings, resulting in a low net leverage profile. The “Extreme Greed” reading of 89.86 on the fear‑greed index reflects a market environment that may be pricing in optimism. Considering the upside potential, strong fundamentals, and pending legal risk, the stock appears attractive for investors with a medium‑ to long‑term horizon while warranting caution in the near term.
Management highlighted strong new business with enterprise leaders despite a slowdown in March due to geopolitical factors. A class‑action securities‑fraud lawsuit filed in May adds a material legal headwind that could affect investor sentiment. Gartner’s operating margin of 20.5% and free cash flow generation of $1.06 bn demonstrate robust profitability and cash generation. The balance sheet shows a high debt‑to‑equity ratio driven by substantial cash holdings, resulting in a low net leverage profile. The “Extreme Greed” reading of 89.86 on the fear‑greed index reflects a market environment that may be pricing in optimism. Considering the upside potential, strong fundamentals, and pending legal risk, the stock appears attractive for investors with a medium‑ to long‑term horizon while warranting caution in the near term.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish MACD and price below short‑term SMA
- Class‑action lawsuit creating legal uncertainty
- High short‑term volatility and decreasing volume
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Undervaluation relative to DCF and industry PE
- Q1 earnings beat and strong free cash flow
- Positive outlook for global IT spending growth
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Sustained high operating margins and ROE
- Recurring subscription‑based revenue model
- Low beta and diversified geographic footprint
Key Metrics & Analysis
Financial Health
Revenue Growth-1.50%
Profit Margin11.44%
P/E Ratio14.6
ROE94.88%
ROA9.38%
Debt/Equity5293.41
P/B Ratio158.6
Op. Cash Flow$1.4B
Free Cash Flow$1.1B
Industry P/E36.8
Technical Analysis
TrendNeutral
RSI40.3
Support$141.74
Resistance$180.45
MA 20$159.31
MA 50$154.55
MA 200$202.71
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86
Valuation
Fair Value$185.15
Target Price$167.00
Upside/Downside12.71%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.77
Volatility52.17%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.